BRIEF-FDA Says Integra Lifesciences Identified Packaging Failures Related To Medihoney Wound & Burn Products & CVS Wound Gel Products
Reuters
Jan 23
BRIEF-FDA Says Integra Lifesciences Identified Packaging Failures Related To Medihoney Wound & Burn Products & CVS Wound Gel Products
Jan 22 (Reuters) - FDA:
FDA: INTEGRA LIFESCIENCES IDENTIFIED PACKAGING FAILURES RELATED TO MEDIHONEY WOUND & BURN PRODUCTS THAT COULD LEAD TO A BREACH IN THE STERILE BARRIER
FDA:INTEGRA LIFESCIENCES IDENTIFIED PRODUCTION AND PROCESS CONTROL ISSUES FOR CERTAIN CVS WOUND GEL PRODUCTS
FDA:AS OF DECEMBER 19, 2025, INTEGRA LIFESCIENCES HAS REPORTED 11 SERIOUS INJURIES RELATED TO MEDIHONEY WOUND AND BURN PRODUCTS
FDA:AS OF DECEMBER 19, 2025, INTEGRA LIFESCIENCES HAS REPORTED THREE SERIOUS INJURIES RELATED TO CVS WOUND GEL PRODUCTS
FDA:AS OF DECEMBER 19, 2025, INTEGRA LIFESCIENCES HAS REPORTED NO DEATHS ASSOCIATED WITH MEDIHONEY WOUND AND BURN PRODUCTS & CVS WOUND GEL PRODUCTS
Source text: [ID:]
Further company coverage: IART.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.